NURS 8024 Pharm Exam 3 (antimicrobial part 2) 2025
COMPLETE QUESTIONS With 100% Verified Solutions,
Bacterial protein synthesis inhibitors - (ANSWER)Clindamycin
Clindamycin - (ANSWER)Time dependent killing
Inhibits protein synthesis
Bacteriostatic
90% bioavailability
Clindamycin mechanism of resistance - (ANSWER)Altered target sites
Active efflux (pushes drug out of the cell)
Clindamycin ADE - (ANSWER)GI upset
Skin rash
Neutropenia
Superinfections such a c diff pseudomembranous
- don't use if patient has history of c diff
Clindamycin indications - (ANSWER)Gram positive
Prophylaxis of endocarditis in valve patients with PCN allergy
Oxazolidinones - (ANSWER)New class of bacterial protein synthesis inhibitors
, Time dependent killing
Prevents formation of ribosome complex
Bacteriostatic & Bactericidal against strep
Linezolid - (ANSWER)Protein synthesis inhibitor
100% bioavailability orally
30% CSF penetration
Linezolid ADE - (ANSWER)Hematologic
Increased thrombocytopenia risk
Anemia, neutropenia, neuropathy
Optic & peripheral neuropathy
Serotonin syndrome with SSRIs
Linezolid Indications - (ANSWER)Gram positive resistant
VRE, HCAP, CAP
Complicated skin & tissue infections
Off label use for TB
No resistance currently
Fluoroquinolones - (ANSWER)Norfloxacin (1st gen)
COMPLETE QUESTIONS With 100% Verified Solutions,
Bacterial protein synthesis inhibitors - (ANSWER)Clindamycin
Clindamycin - (ANSWER)Time dependent killing
Inhibits protein synthesis
Bacteriostatic
90% bioavailability
Clindamycin mechanism of resistance - (ANSWER)Altered target sites
Active efflux (pushes drug out of the cell)
Clindamycin ADE - (ANSWER)GI upset
Skin rash
Neutropenia
Superinfections such a c diff pseudomembranous
- don't use if patient has history of c diff
Clindamycin indications - (ANSWER)Gram positive
Prophylaxis of endocarditis in valve patients with PCN allergy
Oxazolidinones - (ANSWER)New class of bacterial protein synthesis inhibitors
, Time dependent killing
Prevents formation of ribosome complex
Bacteriostatic & Bactericidal against strep
Linezolid - (ANSWER)Protein synthesis inhibitor
100% bioavailability orally
30% CSF penetration
Linezolid ADE - (ANSWER)Hematologic
Increased thrombocytopenia risk
Anemia, neutropenia, neuropathy
Optic & peripheral neuropathy
Serotonin syndrome with SSRIs
Linezolid Indications - (ANSWER)Gram positive resistant
VRE, HCAP, CAP
Complicated skin & tissue infections
Off label use for TB
No resistance currently
Fluoroquinolones - (ANSWER)Norfloxacin (1st gen)